Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders (Q34466246)

2 August 2017

Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders (English)

1 reference

2 August 2017

Battmann T

1

1 reference

2 August 2017

Branche C

2

1 reference

2 August 2017

Bouchoux F

3

1 reference

2 August 2017

Cerede E

4

1 reference

2 August 2017

Philibert D

5

1 reference

2 August 2017

Goubet F

6

1 reference

2 August 2017

Teutsch G

7

1 reference

2 August 2017

Gaillard-Kelly M

8

1 reference

2 August 2017

1 January 1998

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

2 August 2017

1 reference

2 August 2017

64

1 reference

2 August 2017

1-2

1 reference

2 August 2017

103-111

1 reference

Antiandrogens: clinical applications

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

How the study of the biological activities of antiandrogens can be oriented towards the clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

"Casodex" (ICI 176,334)--a new, pure, peripherally-selective anti-androgen: preclinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

Nilutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

Anti-Androgenicity of Flutamide and its Metabolite Sch 16423

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

RU 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

Screening for anti-hormones by receptor studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

Identification of androgen response elements in mouse mammary tumour virus and the rat prostate C3 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

Stable transfection of androgen receptor and MMTV-CAT into mammalian cells: inhibition of cat expression by anti-androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

Pharmacology of antiandrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

Preliminary pharmacokinetics and metabolism of novel non-steroidal antiandrogens in the rat: Relation of their systemic activity to the formation of a common metabolite

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

Regulation of prostate growth

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

The Effect of the Steroidal Androgen Receptor Antagonist, Win 49,596, on the Prostate and Testis of Beagle Dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

Effects of a new steroidal antiandrogen, TZP-4238 (17 alpha-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3, 20-dione), on spontaneously developed canine benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

Development of a model for the induction of estrogen-related prostatic hyperplasia in the dog and its response to the aromatase inhibitor 4-hydroxy-4-androstene-3,17-dione: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2897%2900151-9

7 January 2021

10.1016/S0960-0760(97)00151-9

Identifiers

DOI

1 reference

2 August 2017

1 reference